Home » Topics » BioWorld Science

BioWorld Science
RSS

Nullifying necrosis: unfolded protein response inhibitors fight flesh-eating bacteria

Aug. 6, 2021

MYMD-1 shows the ability to suppress cytokine storm in human cells

Aug. 6, 2021

Clene provides topline data from REPAIR-PD and REPAIR-MS studies

Aug. 6, 2021

First patient dosed in IMP-MEL study of PORT-2 for the treatment of melanoma and NSCLC

Aug. 6, 2021

INPP5D inhibition reduces amyloid pathology in Alzheimer's disease model

Aug. 6, 2021

Exicure provides updated interim data from phase Ib/II study of cavrotolimod

Aug. 6, 2021

Enrollment begins in phase II study of Stemedica's itMSCs in patients with COVID-19

Aug. 6, 2021

Aptahem reports positive preliminary results from GLP studies of Apta-1

Aug. 6, 2021

New thyroid hormone receptor agonists divulged by Eccogene

Aug. 6, 2021

Hisun Accuray Therapeutics, Zhejiang Hisun Pharmaceutical present SHP-2 inhibitors

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...